Se espera que el mercado mundial de diagnóstico de sepsis crezca a una tasa anual compuesta del 8,85 % entre 2022 y 2029. Se espera que alcance más de 979,13 millones de dólares en 2029 desde los 469,22 millones de dólares en 2020.
La sepsis es una enfermedad potencialmente mortal que se produce cuando el sistema inmunitario del cuerpo destruye sus propios tejidos en respuesta a una infección. Cuando los sistemas del cuerpo que luchan contra las infecciones se activan, los órganos funcionan mal y de manera inadecuada. La sepsis puede provocar un choque séptico, que es una caída abrupta de la presión arterial que puede provocar daños graves en los órganos e incluso la muerte. El tratamiento con antibióticos y líquidos intravenosos lo antes posible mejora las posibilidades de supervivencia.
Además, la creciente financiación pública y privada para las actividades de investigación de diagnóstico de la sepsis, la creciente carga de enfermedades infecciosas, el creciente número de casos de sepsis y el aumento de los programas gubernamentales para aumentar la conciencia sobre la sepsis probablemente impulsarán la demanda de dispositivos de diagnóstico de la sepsis. Se prevé que el mercado de diagnóstico de la sepsis se desarrolle significativamente durante el período de pronóstico, debido a un aumento en la carga de sepsis y un aumento en la población geriátrica mundial. Los principales impulsores del crecimiento del mercado incluyen un aumento en la financiación gubernamental para los esfuerzos de investigación relacionados con la sepsis, así como un aumento en la prevalencia de enfermedades infecciosas. Por otro lado, se espera que el desarrollo de enfoques de diagnóstico rápido/punto de atención para diagnósticos tempranos de sepsis cree oportunidades lucrativas para los principales participantes de la industria durante todo el período de proyección.
ATRIBUTO | DETALLES |
Periodo de estudio | 2020-2029 |
Año base | 2021 |
Año estimado | 2022 |
Año pronosticado | 2022-2029 |
Periodo histórico | 2018-2020 |
Unidad | Valor (millones de USD) |
Segmentación | Por producto, por método, por tipo de prueba, por patógeno, por tecnología, por usuario final, por región |
Por producto |
|
Por método |
|
Por tipo de prueba |
|
Por patógeno |
|
Por tecnología |
|
Por el usuario final |
|
Por región |
|
Sin embargo, el alto costo de los instrumentos de diagnóstico automatizados limita la expansión del mercado. La sepsis es una enfermedad potencialmente mortal que debe ser detectada y tratada lo antes posible por expertos en atención médica capacitados. En todo el mundo, existe una escasez crónica de expertos competentes; solo la mitad de los pacientes con sepsis grave que son trasladados por el sistema EMS cuentan con un paramédico. La escasez de paramédicos calificados tiene un impacto en todas las fases de la atención al paciente, incluida la concienciación de la sepsis, la evaluación de los pacientes para detectar la presencia de sepsis y la toma de decisiones adecuadas sobre el tratamiento.
La pandemia de COVID-19 se extendió por todo el mundo y eso interrumpió la cadena de suministro a nivel mundial. Debido al cierre, el proceso de producción de todas las industrias se detuvo, cerró o desvió hacia la recuperación de los pacientes de COVID y eso resultó en una disminución de la demanda de diagnósticos de sepsis en el mercado. La industria de las cámaras médicas ha sufrido como resultado de los retrasos en los procedimientos médicos y las cirugías. A medida que los mercados mundiales se han abierto, se están enfocando en tener más cámaras para la supervisión y se espera que ganen un crecimiento potencial en el mercado de diagnóstico de sepsis.
The Sepsis Diagnostics market size had crossed USD 32.50 million in 2020 and will observe a CAGR of more than 8.85% up to 2029 driven by the rise in sepsis diseases and diagnostic surgeries in healthcare industry.
North America accounted for a 42% share of the sepsis diagnostics market in 2020 and is expected to maintain its dominance during the forecast period.
Rising number of sepsis occurrences, and growing government programmes to raise sepsis awareness are all likely to drive demand for sepsis diagnostic devices and thus market growth. Development of quick diagnosis/point-of-care approaches for early sepsis diagnoses is expected to create lucrative opportunities to major industry participants. But the high cost of automated diagnostics instruments limits the market expansion.
bioMérieux, Becton, Dickinson and Company, Danaher Corporation, T2 Biosystems, Luminex, Roche Diagnostics, Thermo Fisher Scientific, Bruker Corporation, Abbott Laboratories, Immunexpress, Axis-Shield Diagnostics, Quidel Corporation, and others., are among the leading players in the global sepsis diagnostics market.
Presence of a highly developed healthcare system, high adoption of innovative sepsis diagnostic technologies among medical professionals, a rising number of surgical procedures, in the North American region, it accounted for a large share of sepsis diagnostics market in 2020 and is expected to maintain its dominance during the forecast period.
Due to its large patient population, increasing sepsis diagnostics usage in healthcare industry, as well as the rise in geriatric population, Asia-Pacific is expected to have the highest CAGR in coming years.
The global sepsis diagnostics market is segmented by product, method, test type, pathogen, technology, end user and region.
Based on product segment, the sepsis diagnostics market includes Blood Culture Media, Reagents, Assay, Instruments, Software. During the projection period, the blood culture media segment had the greatest market share. This proportion may be ascribed to the increasing use of blood culture media for the diagnosis of sepsis by hospitals and pathology labs, as well as an increase in the market availability of blood culture media.
The sepsis diagnostics market can be classified based on the method, that is Automated Diagnostics, Conventional Diagnostics. Due to the greater cost of automated diagnostics equipment, the traditional diagnostics segment currently leads the market and is likely to stay dominant over the forecast period.
Based on test type segment, the sepsis diagnostics market includes Lab, POC. The laboratory testing segment now leads the market and is projected to do so for the foreseeable future. This is due to the fact that lab testing is more accurate than point-of-care testing for detecting sepsis. Furthermore, the increased dependence of patients and clinicians on laboratory testing drives the growth of the sepsis diagnostic market.
The sepsis diagnostics market can be classified based on the pathogen, that is Bacterial, Viral, Fungal. The bacterial sepsis category held the greatest market share. This increase can be ascribed to an increase in bacterial sepsis cases, an increase in surgical operations, and an increase in the prevalence of HAIs.
Based on technology segment, the sepsis diagnostics market includes Blood Culture, Microbiology, PCR, Sequencing, Biomarkers, Microfluidics, Immunoassays. The blood culture segment held the greatest market share. This proportion can be ascribed to the inexpensive cost of microbiology techniques as well as the widespread usage of blood culture methods for sepsis diagnosis.
Based on end-user segment, the sepsis diagnostics market includes Hospital, Pathology Lab, Research Laboratories & Academic Institutes. The hospitals and specialty clinics have the biggest share of the sepsis diagnostics market. The larger share of this segment can be attributed to the high prevalence of sepsis, as well as the large number of fatalities caused by the illness, the increasing number of patients hospitalized with sepsis, and in-house hospital laboratories performing a large number of blood culture tests to identify blood stream infections (BSIs caused by bacteria, fungi/yeast, or viruses).
[caption id="attachment_10025" align="alignleft" width="680"]The global sepsis diagnostics market key players include bioMérieux, Becton, Dickinson and Company, Danaher Corporation, T2 Biosystems, Luminex, Roche Diagnostics, Thermo Fisher Scientific, Bruker Corporation, Abbott Laboratories, Immunexpress, Axis-Shield Diagnostics, Quidel Corporation, and others.
Various businesses are focusing on organic growth tactics such as new launches, product approvals, and other things like patents and events. Mergers & Acquisitions, partnerships, and collaborations were among the inorganic growth tactics observed in the market. These initiatives such as developing new products and upgrading others, have paved the road for market participants to expand their business. These market players in the sepsis diagnostics market are expected to benefit from attractive growth prospects in the future.
April 12th 2022-bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire Specific Diagnostics, a privately held U.S. based company that has developed a rapid antimicrobial susceptibility test (AST) system that delivers phenotypic AST directly from positive blood cultures.The sepsis diagnostics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
North America has a dominating share in the global sepsis diagnostics market due to well established healthcare industry, rising prevalence of sepsis diseases and diagnostic procedures. Followed by Asia Pacific & Europe, owing to rise in technology advancements, as well as investments by government in funding the healthcare industry and devices.
[caption id="attachment_10026" align="alignleft" width="680"]Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.